A virus called 2019-nCoV that emerged last month in Central China is spreading so fast that it risks becoming a…
McAlinden Research PartnersJanuary 23, 2020
New developments in CRISPR gene editing technology have opened the door to potential cures for 89% of known disease-causing genetic…
McAlinden Research PartnersOctober 29, 2019
As the massive 2700-case litigation against major producers and distributors of opioids continues in Ohio, many lawyers and Attorneys General…
McAlinden Research PartnersOctober 23, 2019
The prevalence of chronic diseases combined with their sky-high price tags is drawing interest to digital therapeutics (DTx), a new…
McAlinden Research PartnersOctober 21, 2019
In two back-to-back blockbuster headlines, Johnson & Johnson was found liable for damages related to the US opioid crisis and…
McAlinden Research PartnersAugust 28, 2019
As litigation against some of the world’s foremost drugmakers finally enters the courtroom, some companies have already settled a number…
McAlinden Research PartnersJune 25, 2019
After some major hiccups last year, new breakthroughs suggest CRISPR is becoming a mainstay in healthcare. The technology is now…
McAlinden Research PartnersMay 28, 2019
At first glance, first quarter earnings for the pharmaceutical sector appear to be largely positive, with only a few nuggets…
McAlinden Research PartnersMay 1, 2019
The world is seeing an escalation of obesity due to energy-sparing technology, sugary drinks, packaged or fast food, and the…
McAlinden Research PartnersMarch 25, 2019
